Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 139
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00442962 | HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV | ||
| NCT00084136 | Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings | ||
| NCT01351025 | Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells | ||
| NCT00665353 | Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance | ||
| NCT04518410 | ACTIV-2: A Study for Outpatients With COVID-19 | ||
| NCT02440789 | Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART) | ||
| NCT01426438 | Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate | ||
| NCT00051831 | Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults | ||
| NCT00376935 | Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults | ||
| NCT00709111 | Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression | ||
| NCT01969058 | Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery | ||
| NCT00063804 | Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men | ||
| NCT00988442 | Telephone Support to Improve Adherence to Anti-HIV Medications | ||
| NCT03001128 | Biomarkers to Predict Time to Plasma HIV RNA Rebound | ||
| NCT01400412 | Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen | ||
| NCT00537394 | Optimizing Treatment for Treatment-Experienced, HIV-Infected People | ||
| NCT05780281 | VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | ||
| NCT00082498 | Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients | ||
| NCT00357552 | Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy | ||
| NCT00096824 | A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175 | ||
| NCT00819390 | Chloroquine for Reducing Immune Activation in HIV- Infected Individuals | ||
| NCT01589497 | Essentiality of INH in TB Therapy | ||
| NCT02412436 | PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB | ||
| NCT00104377 | Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen | ||
| NCT05780463 | MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | ||
| NCT00116285 | Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing | ||
| NCT06856174 | Menopausal HT for Women Living With HIV (HoT) | ||
| NCT06205589 | Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB | ||
| NCT00133146 | Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine | ||
| NCT01936831 | High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB) | ||
| NCT01029249 | Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults | ||
| NCT00830804 | Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults | ||
| NCT01296152 | Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women | ||
| NCT02042248 | A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004 | ||
| NCT05780424 | BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | ||
| NCT00031408 | Consent for Use of Stored Patient Specimens for Future Testing | ||
| NCT01380080 | REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment | ||
| NCT01403051 | High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART | ||
| NCT01315353 | HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women | ||
| NCT01641367 | A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure | ||
| NCT00118898 | Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults | ||
| NCT00608569 | Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults | ||
| NCT04687059 | An Exploratory Study of PQ Grass 27600 SU | ||
| NCT01543958 | Sevelamer for Reducing Endotoxemia and Immune Activation | ||
| NCT01427738 | Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis | ||
| NCT00183261 | Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection | ||
| NCT00414141 | Efficacy and Safety/Tolerability of Grass MATA MPL | ||
| NCT00991302 | Durability of Adherence in Self-Management of HIV | ||
| NCT06729593 | Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial) | ||
| NCT05780437 | AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) |
